TREM2 Inhibition Triggers Antitumor Cell Activity of Myeloid Cells in Glioblastoma

TREM2 loss of function in human macrophages and mouse myeloid cells increased interferon-γ–induced immunoactivation, proinflammatory polarization, and tumoricidal capacity.